For Treatment Augmentation in Patients with Major Depressive Disorder

Update Il y a 4 ans
Reference: EUCTR2011-005200-15

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

): (1) To evaluate the efficacy of MK-6096 in comparison with placebo as treatment augmentation for patients with MDD, based on change from baseline to week 6 in MADRS total score. (2) To assess the safety and tolerability of MK-6096 as augmentation therapy for patients with MDD.


Inclusion criteria

  • depression